SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000878088-11-000072
Filing Date
2011-11-02
Accepted
2011-11-02 16:38:33
Documents
12
Period of Report
2011-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10Q - SEPTEMBER 30, 2011 f3rdqtr1110q110220119amnolin.htm 10-Q 1091630
2 AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENT exhibit101edictamd1tospaq320.htm EX-10.1 25479
3 CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER exhibit31ceocert.htm EX-31.1 7093
4 CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER exhibit31cfocert.htm EX-31.2 7042
5 CERTIFICATION BY THE CHIEF EXECUTIVE OFFICER exhibit32ceo.htm EX-32.1 3563
6 CERTIFICATION BY THE CHIEF FINANCIAL OFFICER exhibit32cfo.htm EX-32.2 3788
  Complete submission text file 0000878088-11-000072.txt   11701290

Data Files

Seq Description Document Type Size
7 prx-20110930.xml EX-101.INS 2586172
8 prx-20110930.xsd EX-101.SCH 73397
9 prx-20110930_cal.xml EX-101.CAL 66056
10 prx-20110930_lab.xml EX-101.LAB 501909
11 prx-20110930_def.xml EX-101.DEF 171292
12 prx-20110930_pre.xml EX-101.PRE 399330
Mailing Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677
Business Address 300 TICE BOULEVARD WOODCLIFF LAKE NJ 07677 201-802-4000
PAR PHARMACEUTICAL COMPANIES, INC. (Filer) CIK: 0000878088 (see all company filings)

IRS No.: 223122182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10827 | Film No.: 111174909
SIC: 2834 Pharmaceutical Preparations